Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption? Weiss A, King TA. Ann Surg Oncol 2023;30:1940-1942.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Weiss A, King TA. Local Regional Recurrence Rates Are Low Following Neoadjuvant Endocrine Therapy: What Are the Remaining Barriers to its Widespread Adoption? Ann Surg Oncol 2023;30:1940-1942.
PMID: 36587173